ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

sildenafil

Also written as “Sildenafil”, “Sildenafil citrate” and “sildenafil citrate”.

Its studies are mostly in Erectile Dysfunction · Pulmonary Arterial Hypertension · Hypertension, Pulmonary · Sexual Dysfunctions, Psychological · Persistent Fetal Circulation Syndrome, led by 10 companies.

Drug pageSildenafil: every studyMany companies study it; this page follows only the 60 they lead. All 330 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Aug 26, 200560 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Viatris470 open or runningphase 4since Aug 26, 2005Aug 26, 2005none ahead
Strategic Science & Technologiesits history only40 open or runningphase 2since Mar 9, 2015Oct 29, 2013none ahead
Hanmi Pharmaceuticalits history only20 open or runningphase 3since Jul 30, 2013Jan 18, 2012none ahead
Daré Bioscienceits history only10 open or runningphase 1since Mar 1, 2023Mar 1, 2023none ahead
Emotional Brain NYits history only10 open or runningphase 2since Aug 17, 2011Aug 17, 2011none ahead
Hamad Medicalits history only10 open or runningphase 3since Mar 11, 2012Mar 11, 2012none ahead
Hoffmann-La Rocheits history only10 open or runningphase 2since Oct 28, 2016Oct 28, 2016none ahead
Laboratório Teuto Brasileiro S/Aits history only10 open or runningphase 3since Mar 15, 2011Mar 15, 2011none ahead
N4 Pharma UKits history only10 open or runningphase 1since Apr 12, 2018Apr 12, 2018none ahead
Pharmtechnologyits history only10 open or runningphase 1since May 6, 2021May 6, 2021none ahead

Also a collaborator on its studies: Pfizer, BDD Pharma and ICOS.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Viatris only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 22 studies since Aug 26, 2005.

  1. May 1, 2007Phase 4 study in Erectile DysfunctionNCT00468650 · 117 enrolled · Mexico
  2. Mar 17, 20083 phase 2 studiesNCT00640458, NCT00645034, NCT00746967
  3. Mar 20, 20086 phase 4 studiesNCT00645268, NCT00644956, NCT00644631 and 3 more
  4. Mar 20, 2008Phase 3 study in Hypertension, PulmonaryNCT00644605 · 275 enrolled · United States, Australia, Belgium and more
  5. Nov 19, 20082 phase 1 studiesNCT00800592, NCT00795938
  6. Mar 19, 2009Phase 1 study in Erectile DysfunctionNCT00866463 · 18 enrolled · United States
  7. May 19, 2009Phase 1 study in Erectile DysfunctionNCT00904748 · 47 enrolled · Brazil
  8. Sep 29, 2009Phase 1 study in HealthyNCT01027117 · 18 enrolled · Belgium
  9. Nov 19, 20103 phase 1 studiesNCT01254396, NCT01254383, NCT01247805
  10. May 10, 2011Phase 2 study in Persistent Fetal Circulation SyndromeNCT01360671
  11. Jun 15, 2012Phase 4 study in Pulmonary Arterial HypertensionNCT01642407 · 6 enrolled · Japan
  12. Aug 1, 20122 phase 1 studies in HealthyNCT01656798, NCT01737203
  13. Sep 17, 2012Phase 3 study in Persistent Fetal Circulation SyndromeNCT01720524 · 59 enrolled · United States, Belgium, Canada and more
  14. Jan 29, 2014Phase 4 study in Pulmonary Arterial HypertensionNCT02060487 · 385 enrolled · United States, Australia, Belgium and more

TargetBeta

PDE5A →read by rule
“Phosphodiesterase 5A inhibitor”ChEMBL 37, by rule

Other programs on PDE5A

ProgramCompanyFurthest phaseStudies
TadalafilruleEli Lillyphase 473

Studies

All 47 Viatris leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02060487Pulmonary Arterial Hypertension · United States, Australia, Belgium and more4TerminatedFeb 26, 2021385
NCT01720524Persistent Fetal Circulation Syndrome · United States, Belgium, Canada and more3CompletedOct 17, 201859
NCT01737203Healthy · Japan1CompletedSep 201253
NCT01656798Healthy · Singapore1CompletedAug 201212
NCT01642407Pulmonary Arterial Hypertension · Japan4CompletedMay 20, 20166
NCT01360671Persistent Fetal Circulation Syndrome2WithdrawnApr 20130
NCT01247805Pulmonary Arterial Hypertention · Belgium1CompletedFeb 201142
NCT01254396Erectile Dysfunction · Singapore1CompletedJan 201112
NCT01254383Erectile Dysfunction · Singapore1CompletedMar 201136
NCT01027117Healthy · Belgium1CompletedSep 200918
NCT00904748Erectile Dysfunction · Brazil1CompletedMar 201047
NCT00866463Erectile Dysfunction · United States1CompletedOct 200818
NCT00800592Hypertension, Pulmonary · Belgium1CompletedDec 200812
NCT00795938Erectile Dysfunction · United States1CompletedNov 200818
NCT00746967Sexual Dysfunctions, Psychological · United States2Completed267
NCT00654082Spinal Cord Injuries · Turkey4Completed88
NCT00654017Erectile Disfunction · Brazil4Completed100
NCT00648596Erectile Dysfunction · Finland, France, Italy and more4Completed780
NCT00644956Erectile Dysfunction · Norway, United Kingdom4Completed56
NCT00644631Erectile Dysfunction · United States4Completed300
NCT00645268Erectile Dysfunction · United States, Canada4Completed300
NCT00645034Prostatic Hyperplasia · United States2Completed20
NCT00644605Hypertension, Pulmonary · United States, Australia, Belgium and more3Completed275
NCT00640458Female Sexual Arousal Disorder · United States, Australia2Completed20
NCT00468650Erectile Dysfunction · Mexico4CompletedFeb 2008117
NCT00454207Hypertension, Pulmonary · Japan3CompletedFeb 200944
NCT00430716Pulmonary Arterial Hypertension · United States, Belgium, Brazil and more4TerminatedMay 25, 2010130
NCT00343200Erectile Dysfunction · United States4Completed371
NCT00323297Pulmonary Arterial Hypertension · United States, Australia, Czechia and more4CompletedAug 2013105
NCT00301262Erectile Dysfunction · Canada4CompletedSep 2007183
NCT00249730Erectile Dysfunction · Canada, France, Greece and more4Completed510
NCT00245596Erectile Dysfunction · France4Completed120
NCT00245258Erectile Dysfunction · Korea, Republic of, Russian Federation, Spain and more4Completed312
NCT00159913Pulmonary Arterial Hypertension · United States, Brazil, Canada and more3CompletedJun 2008235
NCT00159900Erectile Dysfunction · Brazil, Germany, Italy and more4Completed300
NCT00159887Hypertension, Pulmonary · United States, Australia, Belgium and more3Completed260
NCT00159874Pulmonary Arterial Hypertension · United States, Brazil, Chile and more3CompletedDec 2012234
NCT00159861Hypertension, Pulmonary · United States, Belgium, Canada and more3Completed267
NCT00159809Erectile Dysfunction4Completed140
NCT00151463Erectile Dysfunction · Australia4Completed100
NCT00150358Erectile Dysfunction · Mexico4Completed253
NCT00147628Erectile Dysfunction · United States4Completed209
NCT00145483Meniere Disease · Australia4CompletedNov 8, 2006163
NCT00143260Erectile Dysfunction · United States4CompletedMay 2006250
NCT00143221Erectile Dysfunction4Completed350
NCT00141310Pre-Eclampsia · United Kingdom2Terminated76
NCT00137072Erectile Dysfunction · United States4Completed355

How it is read

Names in the registry

  • “Sildenafil”, 27 entries
  • “sildenafil”, 18 entries
  • “Sildenafil citrate”, 14 entries
  • “sildenafil citrate”, 10 entries
  • “Sildenafil Citrate”, 4 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.